💾 Archived View for gmi.noulin.net › mobileNews › 2360.gmi captured on 2023-01-29 at 19:58:12. Gemini links have been rewritten to link to archived content
⬅️ Previous capture (2023-01-29)
-=-=-=-=-=-=-
2010-09-28 12:00:54
Scientists have identified a genetic defect linked to migraine which could
provide a target for new treatments.
A flawed gene found in a family of migraine sufferers could help trigger the
severe headaches, a study in Nature Medicine suggests.
Dr Zameel Cader of the University of Oxford said the discovery was a step
forward in understanding why one in five people suffers from migraines.
The World Health Organization rates it as a leading cause of disability.
A migraine is a severe, long-lasting headache usually felt as a throbbing pain
at the front or on one side of the head.
Some can have a warning visual disturbance, called an aura, before the start of
the headache, and many people also have symptoms such as nausea and sensitivity
to light during the headache itself.
Until now, the genes directly responsible for migraine have been unknown.
In this study, scientists including some from the Medical Research Council's
Functional Genomics Unit at the University of Oxford found a gene known as
TRESK was directly attributable as a cause of migraine in some patients.
'Activate' gene
The study found that if the gene does not work properly, environmental factors
can more easily trigger pain centres in the brain and cause a severe headache.
Cannot play media.You do not have the correct version of the flash player.
Download the correct version
Dr Zameel Cader: Migraine breakthrough is an 'extremely exciting discovery'
The international team used DNA samples from families with common migraine to
identify the defective gene.
Dr Aarno Palotie, from the Wellcome Trust Sanger Institute, said the
breakthrough could eventually lead to new drugs which could switch off the pain
of migraines.
"It opens new avenues for planning new research which possibly could then lead
to new treatments... but of course it's a long road."
Dr Cader, one of the MRC researchers involved in the study, said: "Previous
studies have identified parts of our DNA that increase the risk in the general
population, but have not found genes which can be directly responsible for
common migraine.
"What we've found is that migraines seem to depend on how excitable our nerves
are in specific parts of the brain.
"Finding the key player which controls this excitability will give us a real
opportunity to find a new way to fight migraines and improve the quality of
life for those suffering."
He told the BBC's Today programme the research showed the defective gene in
migraine patients was under-active, therefore causing the headaches.
"So what we want to do is find a drug that will activate the gene," he added.
Professor Peter Goadsby, trustee of The Migraine Trust, said: "The
identification of a mutation in a gene for the potassium channel in a family
with migraine with aura provides both a further important part of the puzzle in
understanding the biology of migraine, and a novel direction to consider new
therapies in this very disabling condition."